KeyCorp Cuts HCA Healthcare (NYSE:HCA) Price Target to $370.00

HCA Healthcare (NYSE:HCA) had its price objective decreased by research analysts at KeyCorp from $420.00 to $370.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s target price indicates a potential upside of 20.54% from the stock’s current price.

HCA has been the subject of a number of other research reports. Oppenheimer raised their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Morgan Stanley lowered their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Trading Up 3.4 %

Shares of HCA Healthcare stock traded up $10.04 on Tuesday, hitting $306.96. 328,360 shares of the company traded hands, compared to its average volume of 978,835. HCA Healthcare has a 52 week low of $276.50 and a 52 week high of $417.14. The company has a market cap of $77.75 billion, a PE ratio of 13.78, a PEG ratio of 1.21 and a beta of 1.64. The stock’s 50 day moving average price is $325.72 and its 200-day moving average price is $354.69. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

Insider Activity

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

Institutional investors have recently made changes to their positions in the stock. Benjamin F. Edwards & Company Inc. purchased a new position in shares of HCA Healthcare in the 2nd quarter worth about $33,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth about $39,000. Canoe Financial LP purchased a new position in shares of HCA Healthcare in the third quarter valued at $41,000. Capital Performance Advisors LLP purchased a new position in HCA Healthcare in the 3rd quarter valued at about $41,000. Finally, Northwest Investment Counselors LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $44,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.